Nrf2/ARE activation of endogenous antioxidant enzymes
Nrf2/ARE Transcriptional Activation · Redox balance and antioxidant defense
Triggers a conformational change in Keap1 that releases Nrf2. Nrf2 then moves into the nucleus, binds the ARE and drives a transcription cascade of hundreds of stress-defense enzymes, including SOD, CAT, GSH-Px and HO-1.
Supplements acting on this mechanism (ranked by strength and evidence)
Sulforaphane
Sulforaphane is a classic inducer of the Nrf2 pathway and can upregulate Nrf2 target genes. In one randomized double-blind human trial, NQO1 rose in nasal lavage cells of smokers. The size of the response varies with tissue, dose and formulation, and not everyone can be expected to respond equally.
R-alpha-lipoic acid (R-ALA)
In one human randomized controlled trial, R-ALA 600 mg/day raised HO-1 expression in peripheral blood mononuclear cells. That dose is higher than the 100–300 mg/day commonly used for this supplement, and there is currently no assurance that a lower dose would have the same effect.
Curcumin
In experimental models, curcumin can modify key cysteine residues in Keap1, promoting Nrf2 entry into the nucleus and upregulating antioxidant enzymes such as HO-1. Most of the evidence comes from mice. Human results are inconsistent, exposure to the free parent compound is low, and pathway activation at usual oral doses is uncertain.
Silybin phytosome
In an animal model of steatohepatitis, oral silybin increased expression of Nrf2 target genes, which supports modulation of this pathway. However, a direct change in Keap1 conformation and induction of GST and HO-1 in the human liver have not been confirmed.
Astragaloside IV
In a rat model of renal ischemia-reperfusion, Nrf2 and HO-1 expression in kidney tissue increased after astragaloside IV treatment. Keap1-related effects and a several-fold induction of HO-1 have not been confirmed in humans, and it is also uncertain whether 20–50 mg/day reaches effective concentrations in human tissues.
Schisandra chinensis standardized extract
In oral experiments in mice, schisandrin B at 25–100 mg/kg upregulated hepatic Nrf2, NQO1 and GST, and the study suggests active metabolites are involved. This is a higher-dose experiment with a single isolated compound, so it cannot be directly equated with ordinary extracts. No evidence of NQO1 or HO-1 induction has been found in humans.
Trans-resveratrol
Some studies suggest resveratrol has Nrf2-related effects, and NQO1 changed in a small human tissue study, but the pathway and dose dependence are still unclear. Human evidence for resveratrol alone is inconsistent. Changes in SOD or Nrf2 gene expression are not enough on their own to prove ARE activation.
Zinc picolinate
Zinc is a structural metal in Cu/Zn-SOD1, but this does not mean it activates Nrf2. In one randomized human trial, NRF2 and SOD-related gene expression rose in myeloma patients who took zinc after transplant. An mRNA change is not enough to show that Nrf2 enters the nucleus, and another study in middle-aged and older adults found no broad benefit for antioxidant markers.
Pterostilbene
After oral pterostilbene, Nrf2/HO-1-related markers rose in mouse lung tissue. This suggests the pathway was activated, but the evidence comes from animal models. Changes in SOD and CAT activity alone cannot prove Keap1 dissociation, and whether pterostilbene binds Keap1 directly, and what effect it has in humans, remain unclear.
L-selenomethionine
Selenium status can affect redox signaling in cells, but maintaining TrxR function and activating Nrf2 are not the same thing. Selenium deficiency alone can activate the Nrf2-ARE stress response in mouse liver. There is currently no reliable evidence that supplemental selenomethionine directly activates Nrf2 in humans.
Broken-wall reishi spore triterpenes (ganoderic acids)
In mouse models, some ganoderic acids can affect Nrf2 and HO-1 markers in the liver. No human study has yet measured specific markers such as NQO1 and HO-1 after oral reishi triterpenes, so the liver-protective findings cannot be applied directly to humans.
Black cumin seed oil extract (thymoquinone)
In animal studies, thymoquinone can promote Nrf2 nuclear translocation and increase HO-1 and NQO1, and cell studies have also observed similar HO-1 induction. However, the evidence for direct covalent modification of Keap1 is insufficient, and the effect in humans after routine oral intake has not been established.
Dandelion root and artichoke complex
In a mouse gut study, dandelion root polysaccharides raised Nrf2-, HO-1- and NQO1-related markers in intestinal tissue. This evidence applies to a specific polysaccharide in a gut model. It cannot be extrapolated to the claim that the phenolic acids in this blend protect the human liver against bile acid reflux.
Gliadin-encapsulated superoxide dismutase (GliSODin)
In a human trial in athletes, red blood cell SOD activity rose after supplementation, but Nrf2, NQO1 and HO-1 were not measured. Animal studies observed changes in antioxidant enzyme activity, but this cannot establish Nrf2/ARE activation in humans. A Peyer’s patch-mediated mechanism has not been confirmed either.